Dr. Robert Lundin, DMD Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 163 Hollis Road, Hollis, ME 04042 Phone: 207-929-3550 Fax: 207-929-3536 |
News Archive
Researchers from the European Molecular Biology Laboratory (EMBL) discovered a new way to make use of drugs' unwanted side effects. They developed a computational method that compares how similar the side effects of different drugs are and predicts how likely the drugs act on the same target molecule. The study, published in Science this week, hints at new uses of marketed drugs.
Magnetic resonance thermometry is the only imaging technique that noninvasively provides temperature distribution in vivo. The water proton resonance frequency shift -based method is the most popular choice for MR temperature monitoring in aqueous tissues.
Watson Pharmaceuticals, Inc., a leading specialty pharmaceutical company, announced today that the United States District Court for the Southern District of Florida has ruled that Watson's generic versions of Mucinex®, Mucinex® D and Mucinex® DM (Guaifenesin, Dextromethorphan HBr/ Guaifenesin, and Pseudoephedrine/Guaifenesin) Extended-Release products, do not infringe U.S. Patent No. 6,372,252.
ALPHAEON Corporation today announced it has entered into a definitive agreement with PhysIOL SA of Belgium, to jointly develop and commercialize an exclusive ALPHAEON-branded Trifocal lens technology. Specific terms of the agreement were not disclosed.
When Vivian Mushahwar first applied to grad school, she wrote about her idea to fix paralysis by rewiring the spinal cord.
› Verified 5 days ago